Maxime Dely: How Artificial Intelligence Will Revolutionize Transfusion Safety
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared on LinkedIn:
”From bag to patient: How artificial intelligence will revolutionize transfusion safety
Artificial intelligence won’t save lives on its own — not yet. But soon, it will learn to, quietly, behind the scenes of hospitals. And in the world of blood transfusion, its impact will be profound.
Every second, blood bags will continue to save lives.
But behind each transfusion will remain a complex equation: compatibility, urgency, availability, traceability… and the persistent risk of human error.
What if AI became our greatest ally in making all this safer?
In the coming years, AI will enter the transfusion chain:
- Predictive analysis of needs to prevent shortages
- Automated detection of anomalies in biological data
- Intelligent matching to minimize rare incompatibilities
Where technicians once relied solely on experience and intuition,
AI will step in — not to replace, but to reinforce human vigilance.
Soon, blood bank organizations and hospitals will deploy models capable of:
- Anticipating peaks in blood demand
- Predicting high-risk transfusions before they occur
But beyond technology, a deeper question will emerge — one of trust and ethics:
How will algorithms and human judgment coexist in a field where every drop counts?
So, what do you think — will AI become a cornerstone of transfusion safety, or remain just a supporting tool?”

Stay updated with Hemostasis Today.
-
Dec 18, 2025, 17:13Daria Camilli on EuroBloodNet and EHC Collaboration for Bleeding Disorders
-
Dec 18, 2025, 16:50Marie Cambot on Innovhem’s Quantification of The HbF/HbS Ratio for SCD
-
Dec 18, 2025, 16:26Yogesh Rathod on Hematological Issues and ICU
-
Dec 18, 2025, 16:09Carlos Doti: I’m Reminded Why ASH is Such a Powerful Close to The Year
-
Dec 18, 2025, 15:23Michael Hadley: Well-Timed ACC Statement Just Out in JACC Journals
-
Dec 18, 2025, 15:12Wolfgang Miesbach on Insights from Guy Young’s ASH2025 Session on Next-Generation Gene Therapy
-
Dec 18, 2025, 14:15Plasma-Derived Therapy for Hemophilia in The Updated European Medicines Agency’s Union List
-
Dec 18, 2025, 13:55Laurent Bertoletti: BAT-VTE is One of 7 Projects Funded Under the EFFECT Trial Call!
-
Dec 18, 2025, 13:34Alexandru Stieber Explores VEXAS Syndrome
